Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Angiotensin receptor blockers modulate the lupus CD4+ T cell epigenome characterized by TNF family–linked signaling
Andrew P. Hart, Jonathan J. Kotzin, Steffan W. Schulz, Jonathan S. Dunham, Alison L. Keenan, Joshua F. Baker, Andrew D. Wells, Daniel P. Beiting, Terri M. Laufer
Andrew P. Hart, Jonathan J. Kotzin, Steffan W. Schulz, Jonathan S. Dunham, Alison L. Keenan, Joshua F. Baker, Andrew D. Wells, Daniel P. Beiting, Terri M. Laufer
View: Text | PDF
Research Article Immunology

Angiotensin receptor blockers modulate the lupus CD4+ T cell epigenome characterized by TNF family–linked signaling

  • Text
  • PDF
Abstract

In systemic lupus erythematosus (lupus), environmental effects acting within a permissive genetic background lead to autoimmune dysregulation. Dysfunction of CD4+ T cells contributes to pathology by providing help to autoreactive B and T cells, and CD4+ T cell dysfunction coincides with altered DNA methylation and histone modifications of select gene loci. However, chromatin accessibility states of distinct T cell subsets and mechanisms driving heterogeneous chromatin states across patients remain poorly understood. We defined the transcriptome and epigenome of multiple CD4+ T cell populations from patients with lupus and healthy individuals. Most patients with lupus, regardless of disease activity, had enhanced chromatin accessibility bearing hallmarks of inflammatory cytokine signals. Single-cell approaches revealed that chromatin changes extended to naive CD4+ T cells, uniformly affecting naive subpopulations. Transcriptional data and cellular and protein analyses suggested that the TNF family members, TNF-α, LIGHT, and TWEAK, were linked to observed molecular changes and the altered lupus chromatin state. However, we identified a patient subgroup prescribed angiotensin receptor blockers (ARBs), which lacked TNF-linked lupus chromatin accessibility features. These data raise questions about the role of lupus-associated chromatin changes in naive CD4+ T cell activation and differentiation and implicate ARBs in the regulation of disease-driven epigenetic states.

Authors

Andrew P. Hart, Jonathan J. Kotzin, Steffan W. Schulz, Jonathan S. Dunham, Alison L. Keenan, Joshua F. Baker, Andrew D. Wells, Daniel P. Beiting, Terri M. Laufer

×

Figure 6

ARB prescription is associated with epigenetic and transcriptional changes in lupus T cells.

Options: View larger image (or click on image) Download as PowerPoint
ARB prescription is associated with epigenetic and transcriptional chang...
(A) Dendrogram representing hierarchically clustered ATAC-Seq profiles of lupus and healthy samples. A single group 2 lupus participant appears twice and was tracked over more than 2 years and resampled (red). (B) Enrichment of signature lupus-associated DARs (Figure 2C, n = 2,683) among naive Th samples in this expanded dataset. Brackets highlight lupus samples grouped into either group 1 (gray) or group 2 (black) based on lupus enrichment score. (C) Enrichment of signature lupus-associated DARs (Figure 2C, n = 2,683) in naive Th cells graphed in healthy individuals and lupus individuals prescribed (ARB+) and not prescribed (ARB–) angiotensin receptor blocking drugs. (D and E) RNA-Seq data GSVA of Hallmark TNF-α signaling via NF-κB (D) and Hallmark IFN-α response gene sets (E) in naive Th cells in group 1 (gray) lupus participants, group 2 (black) lupus participants, and HCs (blue). (F and G) RNA-Seq data GSVA of Hallmark TNF-α signaling via NF-κB (F) and Hallmark IFN-α response gene sets (G) in naive Th in HCs, patients with ARB+ lupus, and patients with ARB– lupus. Error is reported as SD. ATAC-Seq data represent 46 naive Th samples (31 patients with lupus + 1 duplicated second time point sample in A, 14 healthy in B and C). RNA-Seq data represent 36 samples (24 lupus, 12 healthy) (D–G). Across the 24 patients with lupus presented, 9 are prescribed ARBs and 15 are not (F and G). *P < 0.05, **P < 0.01, ***P < 0.001, multiple 1-way ANOVA with Tukey’s multiple comparisons correction (C–G).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts